(Total Views: 399)
Posted On: 02/06/2020 8:13:43 AM
Post# of 153940
“First hint that patient #4 enrolled in bc trial is doing good.”
Well, there is still debate regarding this subject. Remeber last Friday’s PR?
“Initial data from the third patient in the mTNBC trial indicated the CTC dropped to zero after two weeks of treatment with leronlimab.”
I don’t know how last week’s PR could be any clearer in regards to data on 3 mTNBC patients and 1 mBC patient. Everyone is waiting for data on the 4th patient but we already got it and today’s PR confirms that.
“If leronlimab proves to be as effective in this basket trial as we have seen in the first 4 patients in our MBC trials,”
I honestly think that 1. NP’s response to you was incorrect and that 2. Dr. Paterson’s comments in last weeks PR on the new patient in the mTNBC trial just needed an “S” on it to make it plural.
Well, there is still debate regarding this subject. Remeber last Friday’s PR?
“Initial data from the third patient in the mTNBC trial indicated the CTC dropped to zero after two weeks of treatment with leronlimab.”
I don’t know how last week’s PR could be any clearer in regards to data on 3 mTNBC patients and 1 mBC patient. Everyone is waiting for data on the 4th patient but we already got it and today’s PR confirms that.
“If leronlimab proves to be as effective in this basket trial as we have seen in the first 4 patients in our MBC trials,”
I honestly think that 1. NP’s response to you was incorrect and that 2. Dr. Paterson’s comments in last weeks PR on the new patient in the mTNBC trial just needed an “S” on it to make it plural.
(0)
(0)
